Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Laboratoires FILLMED files for Health Canada Approval of ART-FILLER® Injectables in Canada LAVAL, QC, Jan. 21, 2021 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF)...
LAVAL, QC, Nov. 26, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TSX") has approved the...
Strong Ending Cash Balance of $13.9M LAVAL, QC, Nov. 12, 2020 /CNW Telbec/ Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven...
LAVAL, QC, Nov. 5, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology...
Strong Ending Cash Balance of $9.3M LAVAL, QC, Aug. 12, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven...
LAVAL, QC, July 28, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with ...
Positive Adjusted EBITDA1 and Cash Flow LAVAL, QC, May 27, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita" or "the Company"), a growth-oriented,...
LAVAL, QC, May 14, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with...
LAVAL, QC, April 28, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") today announced that pursuant to the exemption provided in Ontario Instrument...
LAVAL, QC, March 24, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company...
Record Annual Revenue of $22.3M Record Adjusted EBITDA of $7.0M up from $1.5M LAVAL, QC, March 18, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX OTC) (US: CRRTF) ("Crescita" or the "Company"), a...
MONTREAL, March 10, 2020 /CNW Telbec/ - The topical analgesic Pliaglis has long been awaited by many doctors and dermatologists in Canada because it offers patients an effective alternative to...
Primary Endpoint Achieved with High Statistical Significance LAVAL, QC, Feb. 11, 2020 /CNW/ – Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial...
LAVAL, QC, Jan. 24, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial dermatology company with manufacturing capabilities and a...
Laval, QC, Jan. 22, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial dermatology company with manufacturing capabilities and a portfolio...
Crescita to Distribute NCTF® and ART FILLER® Injectables in Canada LAVAL, QC, Jan. 20, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita" or the "Company"), a...
Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA1 of $0.9 Million LAVAL, QC, Nov. 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian...
LAVAL, QC, Nov. 5, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of...
CALGARY and LAVAL, QC, Oct. 28, 2019 /CNW/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF)...
LAVAL, QC, Sept. 5, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a...
Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million LAVAL, QC, Aug. 8, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian...
LAVAL, QC, July 16, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...
LAVAL, QC, July 11, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...
LAVAL, QC, July 4, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...
LAVAL, QC, June 26, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TSX") has approved the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.